Speculation has arisen that human fecundity may be declining, possibly a function of exposure to persistent environmental chemicals that resist degradation resulting in various pathways for human exposure. In contrast to considerable animal evidence suggesting adverse effects of such chemicals on reproduction, limited human research has been undertaken. To date, available data stem largely from ten unique study cohorts that have quantified individual chemical exposures in relation to time-to-pregnancy (TTP), which is a measure of couple fecundity. Diminished fecundability odds ratios indicative of longer TTP were observed in all but two studies, although not all findings achieved statistical significance. Persistent chemicals associated with reduced couple fecundity as measured by a longer TTP included bHCH, cadmium, lead, mercury, 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene, TCCD dioxin, and select polybrominated diethers, polychlorinated biphenyls, and perfluorochemicals. Important methodologic limitations need to be considered in weighing the evidence: i) reliance on pregnant women, which may exclude women with the highest exposures if related to the inability to conceive; ii) retrospectively reported TTP, which may be associated with bidirectional reporting errors; and iii) limited attention to male partners or couples' exposures. While current evidence is not inconsistent with animal evidence, concerted efforts to address lingering data gaps should include novel strategies for recruiting couples, the longitudinal measurement of TTP, and the continued enrollment of couples across successive pregnancies. This latter strategy will provide a more complete understanding of the toxicokinetics of chemicals during sensitive windows and their implications for fecundity and its related impairments.
Introduction
An evolving body of evidence suggests that human fecundity, defined as the biologic capacity of men and women for reproduction irrespective of pregnancy intentions (Buck Louis 2011) , may be declining raising concerns about the sustainability of some populations (Daguet 2002 , Lutz et al. 2003 , Skakkebaek et al. 2006 ).
While controversial in many regards, evidence consistent with diminishing male fecundity includes declining semen quality reported by some authors (Zou et al. 2011 , Geoffroy-Siraudin et al. 2012 but not all as recently summarized (Fisch & Braun 2013) , along with higher genital-urinary malformation rates among men with fecundity impairments or reproductive site cancers in comparison to unaffected individuals (Bray et al. 2006 , Skakkebaek et al. 2006 , 2007 , Saravelos et al. 2008 . The relatively high prevalence rates of fibroids, polycystic ovarian syndrome, and endometriosis (Baird et al. 2003 , Azziz et al. 2004 , Gylfason et al. 2010 ) may be suggestive of diminishing female fecundity, while increasing infertility rates may be indicative of diminished couple fecundity (Priskorn et al. 2012 , Thoma et al. 2013 .
Fecundity is now recognized to have implications across the lifespan. For example, boys born with genitalurinary malformations are at increased risk of alterations in semen quality, infertility, and testes cancer in adulthood than unaffected boys (Trussell & Lee 2004 , Bray et al. 2006 . In fact, recent authors have reported semen quality to be positively associated with longevity (Jensen et al. 2009) . Associations between female fecundity and later onset disease have also been reported. For example, girls born small-for-gestation are reported to have poorer adult ovarian development and function relative to adequately sized girls (Ibáñ ez et al 2000) . Girls with low birth weights irrespective of gestation were reported to have biochemical and clinical features characteristic of polycystic ovarian syndrome (Pandolfi et al. 2008) . Similarly, women with polycystic ovaries are at increased risk of gravid disease and metabolic disorders later in adulthood (Talbott et al. 2004) . Infertility was also observed to be associated with gravid diseases such as gestational diabetes (Tobias et al. 2013) . Collectively, the findings in males and, subsequently, females have been conceptualized as suggesting an early origin for onset, or the so-called testicular and ovarian dysgenesis syndromes (Skakkebaek et al. 2001 , Buck Louis et al. 2011a .
Potential reasons for declining fecundity are largely unexplored, although environmental factors are suggested and serve as the impetus for this paper. Attention is directed to persistent chemicals that resist degradation, as indicative by their long half-lives spanning several years for some compounds (www. cdc.gov/exposurereport/pdf/FourthReport.pdf). Such chemicals include 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene (DDE) and its parent compound 1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane (DDT), dioxin, metals, organochlorine pesticides (OCPs), polybrominated biphenyls (PBBs), polybrominated diethers (PBDEs), polychlorinated biphenyls (PCBs), and perfluorochemicals (PFCs). This paper is organized as three questions and concludes with a summary of chemicals reported to adversely affect fecundity using a weight of evidence approach.
How can couple fecundity be assessed relative to environmental chemicals?
A range of possible outcomes can be used to assess either male or female fecundity when considered individually. By contrast, couple fecundity is largely measured by time-to-pregnancy (TTP), which is defined as the number of menstrual cycles or calendar months required to become pregnant. TTP is used globally as a marker of how quickly a couple becomes pregnant, or not. It can also be categorized to denote fecundity-related impairments such as conception delay (TTP, greater than six cycles per month) or infertility (O12 cycles/month) recognizing that neither of these two impairments denotes sterility without further medical investigation.
In prospectively followed couples attempting pregnancy, w80% of women achieve pregnancy within six cycles of trying (Bonde et al. 1998 , Buck Louis et al. 2011b , while 13-18% of couples do not achieve pregnancy within 12 months (Zinman et al. 1996 . Of note are the regional differences in TTP (Juul et al. 1999 , Sanin et al. 2009 . The extent to which such differences in TTP reflect regional variations in semen quality (Jørgensen et al. 2001 , Punab et al. 2002 , Swan et al. 2003 remains to be established.
One important limitation of using TTP as a measure of couple fecundity is that it provides no information as to whether the delays are male, female, or couple mediated. Much of the available research relies on females, not couples. A second data gap is the absence of research that has empirically assessed how male (e.g. semen quality) and female (e.g. ovulatory cycles) fecundity jointly mediates couple fecundity or TTP. This data gap likely reflects the few prospective cohort studies with preconception enrollment of couples conducted to date (Buck et al. 2004) .
While TTP can be estimated with the use of prospective and retrospective designs, the former is considered the gold standard given its ability to longitudinally measure at risk time and incident pregnancy along with other time-varying lifestyle factors such as alcohol consumption or smoking. While reliability is reported to be good for retrospectively measured TTP even after long period of recall (Joffe et al. 1993) , its validity is only good for short recall or within 3-20 months (Zieluis et al. 1992) . However, it has poor validity for longer periods of recall as reflected in bidirectional errors or the underand over-reporting of TTP by women (Cooney et al. 2009 ). Another important methodologic limitation underlying the use of retrospective TTP is digit preference reporting (Ridout & Morgan 1991) .
The fecundability odds ratio (FOR) estimates the probability of pregnancy each menstrual cycle or month, given exposure and conditional on not having achieved pregnancy in the previous cycle. FORs are estimated along with their 95% CI for assessing significance. A FOR !1.0 denotes reduced fecundability or a longer TTP, whereas an FOR O1.0 denotes enhanced fecundability or a shorter TTP. Despite increasing recognition of the importance of lifestyle factors for TTP (Rothman et al. 2013) , only 14% of the variation in TTP was explained by oral contraceptive use, cycle length, age, and parity at the population level, whereas other lifestyle factors were not retained in models (Axmon et al. 2006a ). This finding underscores our limited understanding of the population and individual level determinants of human fecundity and is an important consideration when assessing environmental chemicals.
What research has focused on persistent chemicals and couple fecundity?
Research relying on retrospectively collected TTP Very little research has focused on persistent environmental chemicals and couple fecundity, despite many R98 G M Buck Louis such compounds having been quantified in semen, follicular, and genital track fluid (Wagner et al. 1990 , DeFelip et al. 2004 , Jirsová et al. 2010 . To date, much available research relies on retrospectively ascertained TTP from pregnant women or women with unique residential or lifestyle (i.e. fish consumption) exposures. Axmon et al. (2004) queried 183 sisters of fishermen about TTP and obtained a blood sample for the quantification of plasma PCB congener 153 w20 years following the first planned pregnancy necessitating the need to backwardly extrapolate exposure at the relevant time period for TTP. A positive association was observed suggesting enhanced fecundity or a shorter TTP, including for another subset of wives of fisherman. The findings, however, did not achieve significance. In a subsequent study, Axmon et al. (2006b) recruited pregnant women and their male spouses from Greenland, Kharkiv, and Warsaw and queried them about TTP. FORs !1.0 were observed for male and female serum PCB 153 in Greenland and Kharkiv but not in Warsaw, and female DDE concentrations were also associated with FORs !1.0 but only in Greenland. However, only the findings for female exposures in Greenland achieved significance. Gesink Law et al. (2005) utilized the historic U.S. Collaborative Perinatal Project that enrolled pregnant women from 12 clinical sites in the USA, 1959-1965. Banked serum was analyzed for 390 women for the quantification of 11 PCBs, DDT, and DDE. Women in the highest quintile of PCBs and DDE had a z35% reduction in fecundity or a longer TTP when compared to women in the lowest categories. However, the findings failed to reach significance. Harley et al. (2008) assessed serum DDT and DDE concentrations in 289 pregnant migrant farmworkers participating in the CHAMACOS cohort study in relation to retrospectively collected TTP. FORs were all below one, reflecting reduced (2-9%) fecundity for o,p 0 -DDT, p,p 0 -DDT, and p,p 0 -DDE respectively. Subsequently, Harley et al. (2010) assessed ten serum PBDE congeners for a subset of pregnant women in the CHAMACOS cohort. Only PBDE congener 100 was associated with a significant 40% reduction in fecundity, with findings robust to additional sensitivity analyses given their reliance on retrospective TTP. Cole et al. (2005) utilized a cross-sectional design to quantify OCPs, PCBs, and metals in 41 first-time pregnant couples. Only female blood mercury was associated with reduced fecundity, conferring a 78% significant reduction in fecundity. Dioxin and TTP has been assessed in one study. Specifically, Eskenazi et al. (2010) assessed serum 2,3,7,8-tetrachlorodibenzop-dioxin concentrations in 278 women that were extrapolated back to the time women were attempting pregnancy following a dioxin plant explosion in relation to retrospectively reported TTP for 278 (28%) women. Fecundity was reduced z25%, and a twofold higher odds of infertility or achieving pregnancy after 12C months of trying was also observed for participants.
With regard to PFCs, Fei et al. (2009) utilized banked biospecimens for the quantification of plasma perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS) concentrations among a subset of 1240 pregnant women who participated in the Danish National Birth Cohort and who were queried about TTP during pregnancy. Significant inverse trends were observed for both PFOA and PFOS and TTP, reflecting an w30% reduction in fecundity for women in the highest three quartiles relative to women in the lowest.
Two other pregnancy studies are worth mentioning despite not being directly comparable to research with individual chemical concentrations and TTP. Whitworth et al. (2012) assessed plasma PFOA and PFOS concentrations in 910 pregnant women participating in the Norwegian Mother and Child (MoBA) cohort study with retrospectively collected TTP dichotomized as requiring O12 months for pregnancy vs %12 months. Parous but not nulliparous women in the highest quartiles of PFOA and PFOS had a significant twofold higher odds of a TTP O12 months in comparison to women with lower concentrations. In the PELAGIE cohort, pregnant mothers were queried about their TTP in relation to 14 OCPs, 12 PCBs, and ten PBDEs that were quantified in the cord blood of 394 infants (Chevrier et al. 2013) . Negative associations were observed for most compounds, particularly for total PCBs (54% reduction), p,p 0 -DDE (40% reduction), and two OCPs (bHCH and HCB, 39 and 10% respectively).
Research with prospectively measured TTP
Two prospective cohort studies with preconception enrollment of women have assessed PCBs and PFCs. Buck Louis et al. (2009) recruited 83 women upon discontinuing contraception with daily follow-up through 12 menstrual cycles at risk for pregnancy in the New York State Angler Cohort Study (NYSACS). Both estrogenic and anti-estrogenic PCBs were associated with z68% reduction or more in fecundity, although the findings did not achieve significance. A second prospective cohort study with preconception recruitment of couples followed for 6 months reported by Vestergaard et al. (2012) utilized banked serum from 222 women who participated in the Danish First-Pregnancy Planners Cohort, 1992 -1995 (Bonde et al. 1998 . Of the eight PFCs considered, two metabolites -EtFOSAA and MeFOSS -conferred FORs !1.0 reflecting a 20 and 10% reduction respectively. However, the findings did not achieve significance.
The most recently conducted prospective cohort study with preconception enrollment of both partners of the couple for the specific investigation of environmental influences on human fecundity is the Longitudinal Investigation of Fertility and the Environment (LIFE) Study (Buck Louis et al. 2011b) . Couples were recruited from targeted geographic areas with reported exposures to persistent compounds upon discontinuing contraception. TTP was longitudinally measured using a combination of data from the daily journals completed by both partners and the Clearblue Fertility Monitor, which provided visual prompts to help couples time intercourse relative to ovulation. Pregnancy denoted a positive home pregnancy test on the day of expected menstruation using digital home test kits. Various environmental compounds were associated with diminished fecundity, and surprising few were associated with enhanced fecundity as measured by FORS O1. Specifically, female blood cadmium and male lead concentrations were associated with a 22 and 15% reduction in fecundity respectively when modeled individually . When both partners' blood metals were jointly modeled given the low correlation between partners, male lead concentration continued to reflect an 18% reduction in fecundity. All findings remained significant even after adjusting for relevant covariates. Also, female serum concentrations of PCB congeners 118, 167, and 209, and perfluorooctane sulfonamide (PFOSA) were consistently associated with diminished fecundity, ranging from 18 to 21% . Among male partners, p,p 0 -DDE and PCB congeners 138, 156, 157, 167, 170, 172, and 209 were significantly associated with reduced (17-29%) fecundity denoting a longer TTP. Male partners' concentration of PCB 101 was the only chemical significantly associated with enhanced fecundity or a shorter TTP. Table 1 summarizes the weight of evidence reported by ten different study cohorts that had individual chemical measurements and data on either retrospective or prospective TTP data. This summary table reflects the sparse available data and a preponderance of data relying on pregnant women, retrospective TTP, and the limited attention to male partners. Despite these challenges, all but two studies reported FORs !1.0 for at least one chemical suggesting an association with diminished couple fecundity. However, not all the findings achieved significance. Findings from the LIFE Study corroborate earlier reports, including for female PCB concentrations (Axmon et al. 2006b ), p,p 0 -DDE (Harley et al. 2008 ) when based on male concentrations, and PFOS and PFOSA (Fei et al. 2009 ). Of note is the observation that the magnitude of FORs reported for various persistent chemicals is relatively smaller than those reported for biologic determinants such as oligospermia or gynecologic disorders (i.e. FORs 0.34 and 0.46 respectively) (Vestergaard et al. 2012) , but comparable for those reported for cigarette smoking or serum cotinine concentrations, higher BMIs, and parental ages , Chevrier et al. 2013 .
What are the next steps for answering data gaps?
Globally, two avenues of research may offer insight regarding the relationship between environmental chemicals and couple fecundity. One avenue is to continue to leverage existing pregnancy or birth cohort studies. A number of recent pregnancy cohort studies have been implemented in the past decade, and most have banked biospecimens that may be suitable for continued investigation. Still, such effort will be limited by reliance on women successfully achieving pregnancy and retrospective TTP. If exposures prevent couples from achieving pregnancy, they will be excluded from the study cohort and possibly impact study conclusions. Still, it may be possible to devise strategies to measure exposures of women not achieving pregnancy to empirically assess this lingering question and to foster data-driven decision-making. A second promising avenue is to leverage children from existing birth cohorts and to design prospective TTP studies when they enter reproductive years. This approach will provide information on the woman's in utero exposure and also her exposure at the time she is interested in becoming pregnant. The same would be true for males. Ideally, it would be important to follow couples through all their pregnancy-trying attempts to obtain data relevant for understanding the toxicokinetics of chemicals and their impact on sensitive fecundity endpoints across successive pregnancy attempts. Such an approach would be highly informative for the proper modeling of exposures and reproductive outcomes in the context of a couple's past reproductive performance (e.g. parity) and other relevant factors such as age. Irrespective of approach or any others that may be relevant, every effort should be made to quantify exposures in both partners in keeping with the couple dependent nature of human reproduction. Failure to consider male partners may result in erroneous conclusions when based solely on female exposures.
With increased recognition of the need to model chemical mixtures in keeping with the nature of human exposure, continual efforts to develop statistical models for handling correlated and hierarchical data characteristic of couple-based designs are urgently needed. This work becomes more challenging when attempting to include lifestyle and diet to identify potential modifying factors that may minimize the effects stemming from internal chemical doses and, thereby, promote health and well being. While beyond the focus of this paper, future work should also include measurement of both persistent and non-persistent chemicals, given the growing evidence suggesting an adverse relationship between short-lived compounds such as bisphenol A and phthalates and a spectrum of reproductive endpoints. Adverse effects reported include alterations in hormonal milieu, reduced number of oocytes retrieved, and implanted among couples undergoing assisted reproductive technologies and alterations
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Conclusion
An evolving body of observational research suggests that environmentally relevant concentrations of select persistent environmental chemicals may be affecting human fecundity, as evident as a longer time required for achieving pregnancy. Such subtle changes may easily be missed without continued and purposeful research aimed at the preconception enrollment of couples for longitudinal measurement of sensitive outcomes such as TTP and pregnancy loss. Male-mediated exposures also are important and failure to consider them when assessing couple-dependent outcomes such as TTP or pregnancy loss may result in erroneous conclusions, particularly in the absence of female exposures. Future research will require sophisticated analytic methods that are well grounded within human biology and capable of handling the hierarchical and correlated structure of chemical exposures as we seek to delineate and quantify threats to human fecundity. In the context of emerging chemical signals potentially relevant for human fecundity, this author urges shared collaboration and creative utilization of existing resources from which to answer lingering data gaps. The excellent work reported above that utilized banked biospecimens from pregnancy cohort studies is a step in the right direction but cannot replace the need for prospective cohort studies with preconception enrollment of couples. Novel strategies aimed at recruiting contemporary birth cohorts who are or will be soon testing their fecundity are needed. Such empirical evidence is needed for informing public policy and informed decision-making.
Declaration of interest
The author declares that there is no conflict of interest that could be perceived as prejudicing the impartiality of the review reported. This article is based on work presented at the 7th Copenhagen Workshop on Endocrine Disrupters, which was supported by the Danish Ministry of the EnvironmentEnvironmental Protection Agency. Publication of this special issue was supported by the Society for Reproduction and Fertility. The author declares no known or possible conflicts with the sponsors of the COW meeting.
Funding
This study is supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development. Funding for the LIFE Study was provided by contracts N01-HD-3-3355; N01-HD-3-3356; and NOH-HD-3-3358.
